In addition, the positive association between cyclin D1 expression and tumor progression has been validated in different cancers, including lung adenocarcinoma, head and neck squamous cell carcinoma, and esophageal squamous cell carcinoma (ESCC) (51–53). The gene discussed is CCND1; the disease is neoplasm.